Table of Contents

Global NSAIDs Drug Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

1 Study Coverage

• 1.1 NSAIDs Drug Product
• 1.2 Key Market Segments in This Study
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global NSAIDs Drug Market Size Growth Rate by Type
  • 1.4.2 Generic
  • 1.4.3 Branded
• 1.5 Market by Application
  • 1.5.1 Global NSAIDs Drug Market Size Growth Rate by Application
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Drugstores
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global NSAIDs Drug Production
  • 2.1.1 Global NSAIDs Drug Revenue 2014-2025
  • 2.1.2 Global NSAIDs Drug Production 2014-2025
  • 2.1.3 Global NSAIDs Drug Capacity 2014-2025
  • 2.1.4 Global NSAIDs Drug Marketing Pricing and Trends
• 2.2 NSAIDs Drug Growth Rate (CAGR) 2019-2025
• 2.3 Analysis of Competitive Landscape
  • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 2.3.2 Key NSAIDs Drug Manufacturers
• 2.4 Market Drivers, Trends and Issues
• 2.5 Macroscopic Indicator
  • 2.5.1 GDP for Major Regions
  • 2.5.2 Price of Raw Materials in Dollars: Evolution

3 Market Size by Manufacturers

• 3.1 NSAIDs Drug Production by Manufacturers
  • 3.1.1 NSAIDs Drug Production by Manufacturers
  • 3.1.2 NSAIDs Drug Production Market Share by Manufacturers
• 3.2 NSAIDs Drug Revenue by Manufacturers
  • 3.2.1 NSAIDs Drug Revenue by Manufacturers (2014-2019)
  • 3.2.2 NSAIDs Drug Revenue Share by Manufacturers (2014-2019)
• 3.3 NSAIDs Drug Price by Manufacturers
• 3.4 Mergers & Acquisitions, Expansion Plans

4 NSAIDs Drug Production by Regions

• 4.1 Global NSAIDs Drug Production by Regions
  • 4.1.1 Global NSAIDs Drug Production Market Share by Regions
  • 4.1.2 Global NSAIDs Drug Revenue Market Share by Regions
• 4.2 United States
  • 4.2.1 United States NSAIDs Drug Production
  • 4.2.2 United States NSAIDs Drug Revenue
  • 4.2.3 Key Players in United States
  • 4.2.4 United States NSAIDs Drug Import & Export
• 4.3 Europe
  • 4.3.1 Europe NSAIDs Drug Production
  • 4.3.2 Europe NSAIDs Drug Revenue
  • 4.3.3 Key Players in Europe
  • 4.3.4 Europe NSAIDs Drug Import & Export
• 4.4 China
  • 4.4.1 China NSAIDs Drug Production
  • 4.4.2 China NSAIDs Drug Revenue
  • 4.4.3 Key Players in China
  • 4.4.4 China NSAIDs Drug Import & Export
• 4.5 Japan
  • 4.5.1 Japan NSAIDs Drug Production
  • 4.5.2 Japan NSAIDs Drug Revenue
  • 4.5.3 Key Players in Japan
  • 4.5.4 Japan NSAIDs Drug Import & Export
• 4.6 Other Regions
  • 4.6.1 South Korea
  • 4.6.2 India
  • 4.6.3 Southeast Asia

5 NSAIDs Drug Consumption by Regions

• 5.1 Global NSAIDs Drug Consumption by Regions
  • 5.1.1 Global NSAIDs Drug Consumption by Regions
  • 5.1.2 Global NSAIDs Drug Consumption Market Share by Regions
• 5.2 North America
  • 5.2.1 North America NSAIDs Drug Consumption by Application
  • 5.2.2 North America NSAIDs Drug Consumption by Countries
  • 5.2.3 United States
  • 5.2.4 Canada
  • 5.2.5 Mexico
• 5.3 Europe
  • 5.3.1 Europe NSAIDs Drug Consumption by Application
  • 5.3.2 Europe NSAIDs Drug Consumption by Countries
  • 5.3.3 Germany
  • 5.3.4 France
  • 5.3.5 UK
  • 5.3.6 Italy
  • 5.3.7 Russia
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific NSAIDs Drug Consumption by Application
  • 5.4.2 Asia Pacific NSAIDs Drug Consumption by Countries
  • 5.4.3 China
  • 5.4.4 Japan
  • 5.4.5 South Korea
  • 5.4.6 India
  • 5.4.7 Australia
  • 5.4.8 Indonesia
  • 5.4.9 Thailand
  • 5.4.10 Malaysia
  • 5.4.11 Philippines
  • 5.4.12 Vietnam
• 5.5 Central & South America
  • 5.5.1 Central & South America NSAIDs Drug Consumption by Application
  • 5.5.2 Central & South America NSAIDs Drug Consumption by Countries
  • 5.5.3 Brazil
• 5.6 Middle East and Africa
  • 5.6.1 Middle East and Africa NSAIDs Drug Consumption by Application
  • 5.6.2 Middle East and Africa NSAIDs Drug Consumption by Countries
  • 5.6.3 Turkey
  • 5.6.4 GCC Countries
  • 5.6.5 Egypt
  • 5.6.6 South Africa

6 Market Size by Type

• 6.1 Global NSAIDs Drug Breakdown Dada by Type
• 6.2 Global NSAIDs Drug Revenue by Type
• 6.3 NSAIDs Drug Price by Type

7 Market Size by Application

• 7.1 Overview
• 7.2 Global NSAIDs Drug Breakdown Dada by Application
  • 7.2.1 Global NSAIDs Drug Consumption by Application
  • 7.2.2 Global NSAIDs Drug Consumption Market Share by Application (2014-2019)

8 Manufacturers Profiles

• 8.1 Pfizer
  • 8.1.1 Pfizer Company Details
  • 8.1.2 Company Description
  • 8.1.3 Capacity, Production and Value of NSAIDs Drug
  • 8.1.4 NSAIDs Drug Product Description
  • 8.1.5 SWOT Analysis
• 8.2 GSK
  • 8.2.1 GSK Company Details
  • 8.2.2 Company Description
  • 8.2.3 Capacity, Production and Value of NSAIDs Drug
  • 8.2.4 NSAIDs Drug Product Description
  • 8.2.5 SWOT Analysis
• 8.3 Grunenthal
  • 8.3.1 Grunenthal Company Details
  • 8.3.2 Company Description
  • 8.3.3 Capacity, Production and Value of NSAIDs Drug
  • 8.3.4 NSAIDs Drug Product Description
  • 8.3.5 SWOT Analysis
• 8.4 Bayer
  • 8.4.1 Bayer Company Details
  • 8.4.2 Company Description
  • 8.4.3 Capacity, Production and Value of NSAIDs Drug
  • 8.4.4 NSAIDs Drug Product Description
  • 8.4.5 SWOT Analysis
• 8.5 Sanofi
  • 8.5.1 Sanofi Company Details
  • 8.5.2 Company Description
  • 8.5.3 Capacity, Production and Value of NSAIDs Drug
  • 8.5.4 NSAIDs Drug Product Description
  • 8.5.5 SWOT Analysis
• 8.6 Eli Lilly
  • 8.6.1 Eli Lilly Company Details
  • 8.6.2 Company Description
  • 8.6.3 Capacity, Production and Value of NSAIDs Drug
  • 8.6.4 NSAIDs Drug Product Description
  • 8.6.5 SWOT Analysis
• 8.7 AstraZeneca
  • 8.7.1 AstraZeneca Company Details
  • 8.7.2 Company Description
  • 8.7.3 Capacity, Production and Value of NSAIDs Drug
  • 8.7.4 NSAIDs Drug Product Description
  • 8.7.5 SWOT Analysis
• 8.8 Endo
  • 8.8.1 Endo Company Details
  • 8.8.2 Company Description
  • 8.8.3 Capacity, Production and Value of NSAIDs Drug
  • 8.8.4 NSAIDs Drug Product Description
  • 8.8.5 SWOT Analysis
• 8.9 Merck
  • 8.9.1 Merck Company Details
  • 8.9.2 Company Description
  • 8.9.3 Capacity, Production and Value of NSAIDs Drug
  • 8.9.4 NSAIDs Drug Product Description
  • 8.9.5 SWOT Analysis
• 8.10 Depomed
  • 8.10.1 Depomed Company Details
  • 8.10.2 Company Description
  • 8.10.3 Capacity, Production and Value of NSAIDs Drug
  • 8.10.4 NSAIDs Drug Product Description
  • 8.10.5 SWOT Analysis
• 8.11 Yunnan Baiyao
• 8.12 Teva
• 8.13 J&J
• 8.14 Allergan
• 8.15 Purdue

9 Production Forecasts

• 9.1 NSAIDs Drug Production and Revenue Forecast
  • 9.1.1 Global NSAIDs Drug Production Forecast 2019-2025
  • 9.1.2 Global NSAIDs Drug Revenue Forecast 2019-2025
• 9.2 NSAIDs Drug Production and Revenue Forecast by Regions
  • 9.2.1 Global NSAIDs Drug Revenue Forecast by Regions
  • 9.2.2 Global NSAIDs Drug Production Forecast by Regions
• 9.3 NSAIDs Drug Key Producers Forecast
  • 9.3.1 United States
  • 9.3.2 Europe
  • 9.3.3 China
  • 9.3.4 Japan
• 9.4 Forecast by Type
  • 9.4.1 Global NSAIDs Drug Production Forecast by Type
  • 9.4.2 Global NSAIDs Drug Revenue Forecast by Type

10 Consumption Forecast

• 10.1 Consumption Forecast by Application
• 10.2 NSAIDs Drug Consumption Forecast by Regions
• 10.3 North America Market Consumption Forecast
  • 10.3.1 North America NSAIDs Drug Consumption Forecast by Countries 2019-2025
  • 10.3.2 United States
  • 10.3.3 Canada
  • 10.3.4 Mexico
• 10.4 Europe Market Consumption Forecast
  • 10.4.1 Europe NSAIDs Drug Consumption Forecast by Countries 2019-2025
  • 10.4.2 Germany
  • 10.4.3 France
  • 10.4.4 UK
  • 10.4.5 Italy
  • 10.4.6 Russia
• 10.5 Asia Pacific Market Consumption Forecast
  • 10.5.1 Asia Pacific NSAIDs Drug Consumption Forecast by Countries 2019-2025
  • 10.5.2 China
  • 10.5.3 Japan
  • 10.5.4 Korea
  • 10.5.5 India
  • 10.5.6 Australia
  • 10.5.7 Indonesia
  • 10.5.8 Thailand
  • 10.5.9 Malaysia
  • 10.5.10 Philippines
  • 10.5.11 Vietnam
• 10.6 Central & South America Market Consumption Forecast
  • 10.6.1 Central & South America NSAIDs Drug Consumption Forecast by Country 2019-2025
  • 10.6.2 Brazil
• 10.7 Middle East and Africa Market Consumption Forecast
  • 10.7.1 Middle East and Africa NSAIDs Drug Consumption Forecast by Countries 2019-2025
  • 10.7.2 Middle East and Africa
  • 10.7.3 Turkey
  • 10.7.4 GCC Countries
  • 10.7.5 Egypt
  • 10.7.6 South Africa

11 Upstream, Industry Chain and Downstream Customers Analysis

• 11.1 Analysis of NSAIDs Drug Upstream Market
  • 11.1.1 NSAIDs Drug Key Raw Material
  • 11.1.2 Typical Suppliers of Key NSAIDs Drug Raw Material
  • 11.1.3 NSAIDs Drug Raw Material Market Concentration Rate
• 11.2 NSAIDs Drug Industry Chain Analysis
• 11.3 Marketing & Distribution
• 11.4 NSAIDs Drug Distributors
• 11.5 NSAIDs Drug Customers

12 Opportunities & Challenges, Threat and Affecting Factors

• 12.1 Market Opportunities
• 12.2 Market Challenges
• 12.3 Porter's Five Forces Analysis

13 Key Findings

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
  • 14.1.2 Data Source
• 14.2 Author Details

Global NSAIDs Drug market size will increase to Million US$ by 2025, from Million US$ in 2018, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for NSAIDs Drug.

This report researches the worldwide NSAIDs Drug market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global NSAIDs Drug breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The following manufacturers are covered in this report:
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue

NSAIDs Drug Breakdown Data by Type
Generic
Branded
NSAIDs Drug Breakdown Data by Application
Hospitals
Clinics
Drugstores

NSAIDs Drug Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

NSAIDs Drug Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives are:
To analyze and research the global NSAIDs Drug capacity, production, value, consumption, status and forecast;
To focus on the key NSAIDs Drug manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of NSAIDs Drug :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.